" /> Chromosome 17q11.2 deletion syndrome, 1.4-mb - CISMeF





Preferred Label : Chromosome 17q11.2 deletion syndrome, 1.4-mb;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Neurofibromatosis 1 microdeletion syndrome; Nf1 microdeletion syndrome; Van asperen syndrome;

Description : Approximately 5 to 20% of all patients with neurofibromatosis type I (162200) carry a heterozygous deletion of approximately 1.4 Mb involving the NF1 gene and contiguous genes lying in its flanking regions (Riva et al., 2000; Jenne et al., 2001), which is caused by nonallelic homologous recombination of NF1 repeats A and C (Dorschner et al., 2000). The 'NF1 microdeletion syndrome' is often characterized by a more severe phenotype than that observed in the majority of NF1 patients. In particular, patients with NF1 microdeletion often show variable facial dysmorphism, mental retardation, developmental delay, an excessive number of early-onset neurofibromas (Venturin et al., 2004), and an increased risk for malignant peripheral nerve sheath tumors (De Raedt et al., 2003).;

Inheritance : Autosomal dominant;

Molecular basis : A contiguous gene deletion syndrome involving deletion of 1.4Mb on chromosome 17q11.2;

Neoplasia : Optic glioma (19%); Malignant peripheral nerve sheath tumors (21%);

Prefixed ID : #613675;

Details


You can consult :


Nous contacter.
11/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.